A PROGRAM OF TRANSLATIONAL CARDIOVASCULAR MEDICINE: IDENTIFYING NEW TARGETS FOR PREVENTION AND TREATMENT

转化心血管医学计划：确定预防和治疗的新目标

• 批准号: nhmrc : 1036352
• 负责人: Prof Anthony Dart
• 金额: $ 870.23万
• 依托单位: Baker IDI Heart and Diabetes Institute
• 依托单位国家: 澳大利亚
• 项目类别: Program Grants
• 财政年份: 2013
• 资助国家: 澳大利亚
• 起止时间: 2013-01-01 至 2017-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/program-translational-cardiovascular-prevention-treatment/111011
• 关键词: PROGRAM; TRANSLATIONAL; CARDIOVASCULAR; MEDICINE; IDENTIFYING

Cardiovascular disease (CVD) is the major cause of death and disability in Australia and worldwide, despite signficant advances in treatment. Our team has an international reputation for developing innovative approaches for the treatment of patients with CVD. We will work collaboratively to improve outcomes for people suffering from hypertension, heart attack, heart failure & other serious forms of CVD.

尽管治疗方法取得了重大进展，但心血管疾病（CVD）仍然是澳大利亚和全世界死亡和残疾的主要原因。我们的团队在开发治疗 CVD 患者的创新方法方面享有国际声誉。我们将共同努力，改善高血压、心脏病、心力衰竭和其他严重心血管疾病患者的治疗结果。